These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6270517)

  • 21. Aspects of tolerance to and dependence on cannabis.
    Wikler A
    Ann N Y Acad Sci; 1976; 282():126-47. PubMed ID: 828472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potency of delta 9-THC and other cannabinoids in cannabis in England in 2005: implications for psychoactivity and pharmacology.
    Potter DJ; Clark P; Brown MB
    J Forensic Sci; 2008 Jan; 53(1):90-4. PubMed ID: 18279244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cannabis: pharmacology and toxicology in animals and humans.
    Adams IB; Martin BR
    Addiction; 1996 Nov; 91(11):1585-614. PubMed ID: 8972919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects on variable-interval performance in rats of delta 9-tetrahydrocannabinol and cannabidiol, separately and in combination.
    Zuardi AW; Karniol IG
    Braz J Med Biol Res; 1983 Jul; 16(2):141-6. PubMed ID: 6317104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delta-9-tetrahydrocannabinol, EEG and behavior:the importance of adaptation to the testing milieu.
    Constoe PF; Jones BC; Chin L
    Pharmacol Biochem Behav; 1975; 3(2):173-7. PubMed ID: 1144477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
    Rosenberg EC; Patra PH; Whalley BJ
    Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemistry and pharmacological aspects of furanoid cannabinoids and related compounds: Is furanoid cannabinoids open a new dimension towards the non-psychoactive cannabinoids?
    Anand R; Painuli R; Kumar V; Singh PP
    Eur J Med Chem; 2024 Mar; 268():116164. PubMed ID: 38417219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Δ
    Silveira MM; Adams WK; Morena M; Hill MN; Winstanley CA
    J Psychiatry Neurosci; 2017 Mar; 42(2):131-138. PubMed ID: 28245177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Practical considerations in medical cannabis administration and dosing.
    MacCallum CA; Russo EB
    Eur J Intern Med; 2018 Mar; 49():12-19. PubMed ID: 29307505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Excitatory and depressant effects of delta 9-tetrahydrocannabinol and cannabidiol on cortical evoked responses in the conscious rat.
    Turkanis SA; Karler R
    Psychopharmacology (Berl); 1981; 75(3):294-8. PubMed ID: 6275447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ocular hypotension, ocular toxicity, and neurotoxicity in response to marihuana extract and cannabidiol.
    Colasanti BK; Brown RE; Craig CR
    Gen Pharmacol; 1984; 15(6):479-84. PubMed ID: 6098513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical use of cannabis. Cannabidiol: a new light for schizophrenia?
    Deiana S
    Drug Test Anal; 2013 Jan; 5(1):46-51. PubMed ID: 23109356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The yin and yang of cannabis-induced psychosis: the actions of Δ(9)-tetrahydrocannabinol and cannabidiol in rodent models of schizophrenia.
    Arnold JC; Boucher AA; Karl T
    Curr Pharm Des; 2012; 18(32):5113-30. PubMed ID: 22716133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability.
    O'Brien LD; Wills KL; Segsworth B; Dashney B; Rock EM; Limebeer CL; Parker LA
    Pharmacol Biochem Behav; 2013 Jan; 103(3):597-602. PubMed ID: 23103902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Self-administration of cannabinoids by experimental animals and human marijuana smokers.
    Justinova Z; Goldberg SR; Heishman SJ; Tanda G
    Pharmacol Biochem Behav; 2005 Jun; 81(2):285-99. PubMed ID: 15932767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute effects of Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory evoked mismatch negativity.
    Juckel G; Roser P; Nadulski T; Stadelmann AM; Gallinat J
    Schizophr Res; 2007 Dec; 97(1-3):109-17. PubMed ID: 17884351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction between cannabidiol (CBD) and ∆(9)-tetrahydrocannabinol (THC): influence of administration interval and dose ratio between the cannabinoids.
    Zuardi AW; Hallak JE; Crippa JA
    Psychopharmacology (Berl); 2012 Jan; 219(1):247-9. PubMed ID: 21947314
    [No Abstract]   [Full Text] [Related]  

  • 38. Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids.
    Janoyan JJ; Crim JL; Darmani NA
    Pharmacol Biochem Behav; 2002; 71(1-2):155-62. PubMed ID: 11812518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabidiol in medical marijuana: Research vistas and potential opportunities.
    Rong C; Lee Y; Carmona NE; Cha DS; Ragguett RM; Rosenblat JD; Mansur RB; Ho RC; McIntyre RS
    Pharmacol Res; 2017 Jul; 121():213-218. PubMed ID: 28501518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabidiol attenuates delta 9-tetrahydrocannabinol-like discriminative stimulus effects of cannabinol.
    Hiltunen AJ; Järbe TU
    Eur J Pharmacol; 1986 Jun; 125(2):301-4. PubMed ID: 3017729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.